Early infliximab trough levels in paediatric IBD patients predict sustained remission

Background: Exposure–response studies have shown that higher infliximab concentrations are associated with better outcomes in inflammatory bowel disease. There is little agreement about the optimal time to measure infliximab levels in children. Objectives: We aimed to evaluate whether trough levels...

Full description

Bibliographic Details
Main Authors: Nanja Bevers, Arta Aliu, Dennis R. Wong, Bjorn Winkens, Anita Vreugdenhil, Marieke J. Pierik, Luc J. J. Derijks, Patrick F. van Rheenen
Format: Article
Language:English
Published: SAGE Publishing 2024-01-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/17562848231222337